drugset / Trial / NCT00022308

Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

NCT00022308 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy and radiation therapy in treating patients who have locally advanced non-small cell lung cancer.

Timeline

Start
1999-01
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule 30 mg/m2 Intravenous
Subject Irinotecan Small molecule 40 mg/m2 Intravenous
Subject Irinotecan Small molecule 50 mg/m2 Intravenous
Background Cisplatin Other / unclassified 25 mg/m2 —

Indications